Lithium Argentina reported robust third quarter 2026 results, generating $95 million in operating cash flow from its Cauchari-Olaroz lithium project, operating at 95% capacity. The company produced 9,550 tonnes of lithium carbonate, maintaining a 67% cash operating margin despite higher energy costs and currency impacts. Key milestones include progressing the Stage 2 expansion, which aims to increase production capacity by 45,000 tonnes annually with first production targeted for 2028, and closing a joint venture for the PPG project. Financially, Lithium Argentina strengthened its balance sheet with a $180 million convertible debenture from Ganfeng and repurchased $200 million of convertible notes, positioning itself well for future growth and market challenges.
Lithium Argentina's third quarter 2026 results provide context for readers interested in market activity. As of Nov 10, 2026 18:12 WIB, out of 150 priced US stocks tradable on Pluang, 76 rose and 62 fell. Notable movers include PLUG (Plug Power Inc) at USD 1.54 with a 1-day change of +2.67%, and a typical hold time on Pluang of 43 days, with Pluang order activity showing 72% Sell and 28% Buy.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
